Helical peptide models for protein glycation: Proximity effects in catalysis of the Amadori rearrangement

Chemistry and Biology

Volumn 8, Issue 7, 2001, Pages 611-625

  Venkatraman, Janani ^a   Aggarwal, Kamna ^a   Balaram, P ^a,b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Amadori rearrangement; Catalysis; Electrospray ionization mass spectrometry; Helical peptide model; Protein glycation

Indexed keywords

ASPARTIC ACID; GLUCOSE; PEPTIDE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; GLYCOSYLATION; KINETICS; PROTEIN SECONDARY STRUCTURE;

ASPARTIC ACID; CATALYSIS; GLUCOSE; GLYCOSYLATION; KINETICS; MODELS, MOLECULAR; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0034938792     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(01)00036-9     Document Type: Article

References (72)

1. Negative consequences of glycation
2. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus
3. Role of the Maillard reaction in diabetes mellitus and diseases of aging
4. Nonenzymatic glycosylation: Role in the pathogenesis of diabetic complications
5. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease
6. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications
7. Nonenzymatic glycation of collagen in aging and diabetes
8. Diabetes, advanced glycation end products and vascular disease
9. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
10. Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts
11. Glucosylation of human lens protein and cataractogenesis
12. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction
13. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain
14. Hemoglobin-AGE: A circulating marker of advanced glycosylation
15. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin: A study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content
16. A new N-terminal blocking group involving a Schiff base in hemoglobin AIc
17. Structure of hemoglobin AIc: Nature of the N-terminal beta chain blocking group
18. Further identification of the nature and linkage of the carbohydrate in hemoglobin AIc
19. Sites of nonenzymatic glycosylation of human hemoglobin A
20. Schiff base adducts of glyceraldehyde with hemoglobin. Differences in the Amadori rearrangement at the alpha-amino groups
21. Amadori rearrangement potential of hemoglobin at its glycation sites is dependent on the three-dimensional structure of protein
22. The principal site of nonenzymatic glycosylation of human serum albumin in vivo
23. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites
24. Site selectivity in the glycation of alpha A- and alpha B-crystallins by glucose
25. Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites
26. Glycation of amino groups in protein: Studies on the specificity of modification of RNase by glucose
27. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies
28. Sites of glycation of human and horse liver alcohol dehydrogenase in vivo
29. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites
30. Nonenzymatic glycosylation of erythrocytic proteins in normal and diabetic subjects. Enzymes of nucleoside and nucleotide metabolism
31. Estimation and characterization of glycosylated carbonic anhydrase I in erythrocytes from patients with diabetes mellitus
32. Enzymic glycation may decrease activity of erythrocytic delta-aminolevulinate dehydratase in diabetes mellitus
33. Effect of phosphate on the kinetics and specificity of glycation of protein
34. Sequence dependent reactivity of model peptides with glyceraldehyde
35. Studies on the Amadori rearrangement in a model system: Chromatographic isolation of intermediates and product
36. Structural characteristics of alpha-helical peptide molecules containing Aib residues
37. Stereochemical control of peptide folding
38. X-ray crystallography of peptides: The contributions of the Italian laboratories
39. Crystal structure of the α-helical undecapeptide Boc-L-Ala-Aib-Ala-Aib-Ala-Glu(OBzl)-Ala-Aib-Ala-Aib-Ala-OMe
40. Factors governing helical preference of peptides containing multiple alpha, alpha-dialkyl amino acids
41. The stereochemistry of peptides containing α-aminoisobutyric acid
42. De novo design: Backbone conformational constraints in nucleating helices and beta-hairpins
43. Deciphering rules of helix stability in peptides
44. Circular dichroism of peptides
45. Circular dichroism
46. Large differences in the helix propensities of alanine and glycine
47. Aromatic side-chain contribution to far-ultraviolet circular dichroism of helical peptides and its effect on measurement of helix propensities
48. Large circular dichroism ellipticities for N-templated helical polypeptides are inconsistent with currently accepted helicity algorithms
49. What is hemoglobin AIc? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry
50. Potential of electrospray mass spectrometry for quantifying glycohemoglobin
51. Quantification of glycated hemoglobin by electrospray ionization mass spectrometry
52. Relative quantification of glycated Cu-Zn superoxide dismutase in erythrocytes by electrospray ionization mass spectrometry
53. A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects
54. The in vivo glyco-oxidation of alpha- and beta-globins investigated by matrix-assisted laser desorption/ionization mass spectrometry
55. Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry
56. A highly specific method for the characterization of glycation and glyco-oxidation products of globins
57. Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry
58. Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG
59. Mass spectrometric study on the protein chemical modification of uremic patients in advanced Maillard reaction
60. Schiff base adducts of hemoglobin. Modifications that inhibit erythrocyte sickling
61. Mutarotation, hydrolysis and rearrangement reactions of glycosylamines
62. Semicarbazone formation from pyridoxal, pyridoxal phosphate and their Schiff bases
63. Nucleophilic catalysis of semicarbazone formation by anilines
64. The enzymatic oxidation of pyridoxine and pyridoxamine phosphates
65. Amadori rearrangement of glyceraldehyde-hemoglobin Schiff base adducts. A new procedure for the determination of ketoamine adducts in proteins
66. A spectroscopic study of glycated bovine alpha-crystallin: Investigation of flexibility of the C-terminal extension, chaperone activity and evidence for diglycation
67. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
68. Formation of two-carbon sugar fragment at an early stage of the browning reaction of sugar wth amine
69. Role of sugar fragmentation in the Maillard reaction
70. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein
71. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process
72. New biomarkers of Maillard reaction damage to proteins